DaVita Clinical Research Launches New Advisory Committee Preparation Services
September 27 2011 - 9:00AM
Business Wire
DaVita Clinical Research® (DCR®), a provider of clinical
research services focused on kidney research as well as a multitude
of specialty therapeutic populations, will launch their new
Advisory Committee Preparation Services at the 2011 Regulatory
Affairs Professionals Society (RAPS): The Regulatory Convergence.
DCR will be at booth #107 during the Oct. 22-26, 2011, meeting in
Indianapolis.
DCR’s team helps lead drug and device sponsors from presentation
outlines through execution at FDA Advisory Committee meetings.
Sponsors benefit from a strategic partnership with dedicated
presentation experts who translate messages into powerful slides in
real time. DCR’s team, which has participated in more than 20
advisory committee meetings during the past six years, works
side-by-side with sponsors to help ensure advisory committee
communication is complete and effective.
The Advisory Committee Preparation Services are divided into two
segments: presentation development and presentation execution.
DCR’s role in presentation development is to create slides for
sponsors that serve as powerful visual aids. Then, through
presentation execution services – mock rehearsals, Q&A
preparation and slide retrieval – the DCR team facilitates the
effective delivery of those slides for sponsors. Similar services
are available for other face-to-face meetings between sponsors and
FDA, such as type A/B/C meetings.
DCR is pleased to announce as a part of this expansion the
addition of Lesley M. Smith to the DCR team. Smith has
distinguished herself as both an able practitioner and scholar in
the area of strategic communication. She recently earned a M.A. in
strategic communication from the University of North Carolina at
Chapel Hill. She is the only slide developer in the advisory
committee preparation industry to write academically on the topic,
conducting research on the presentation of data at drug advisory
committee meetings.
“Successful slide development is a coordinated effort between
clinical, regulatory and communication expertise,” stated Mahesh
Krishnan, vice president of clinical research at DCR. “Professional
communicators move pharmaceutical teams toward their goal in a way
no other function can – a lesson I learned from my own experience
preparing for an advisory committee meeting.”
With a staff that is fully committed to advancing the knowledge
and practice of kidney care, DCR brings unsurpassed knowledge,
skill and expertise to pharmaceutical research, helping ensure the
success of clinical trials.
DaVita, DaVita Clinical Research and DCR are registered
trademarks of DaVita Inc. All other trademarks are the property of
their respective owners.
About DaVita Clinical Research
DaVita Clinical Research (DCR), a wholly owned subsidiary of
DaVita Inc., is committed to advancing the knowledge and practice
of kidney care. DCR brings unsurpassed knowledge, skill, and
expertise to pharmaceutical research, ensuring the success of their
clients’ clinical trials. DCR’s clinical expertise ranges from
designing the study to preparing and submitting the final report.
DCR’s Early Clinical Research unit (Phase I-IIa) and Clinical
Development network of physicians and investigative sites, Health
Economics and Central Laboratory are focused on providing
world-class clinical research in both complex/specialty populations
and therapeutic areas as well as CKD and ESRD populations needed to
meet clinical goals. To learn more about DCR, visit
www.davitaclinicalresearch.com.
About DaVita
DaVita Inc., a Fortune 500® company, is a leading provider of
kidney care in the United States, delivering dialysis services to
patients with chronic kidney failure and end stage renal disease.
DaVita strives to improve patients’ quality of life by innovating
clinical care, and by offering integrated treatment plans,
personalized care teams and convenient health-management services.
As of June 30, 2011, DaVita operated or provided administrative
services at 1,669 dialysis facilities, serving approximately
131,000 patients. DaVita supports numerous programs dedicated to
creating positive, sustainable change in communities around the
world. The company’s leadership development initiatives and social
responsibility efforts have been recognized by Fortune, Modern
Healthcare, Newsweek and WorldBlu. For more information, please
visit www.davita.com.
DaVita (NYSE:DVA)
Historical Stock Chart
From May 2024 to Jun 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Jun 2023 to Jun 2024